Frequency of hepatitis B virus in regularly blood transfused beta thalassaemia major patients

Pakistan Paediatric Journal

Volumn 33, Issue 3, 2009, Pages 153-156

  Khan Burki, Muhammad Fayaz ^a   Hassan, Mumtaz ^a   Ali, Liaqat ^a   Wadood, Mufti Zubair ^a  

^a Children Hospital Islamabad   (Pakistan)

Author keywords

Blood transfusion; Hepatitis B virus; Thalassaemia

Indexed keywords

ANAMNESIS; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREQUENCY ANALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INFANT; MALE; PHYSICAL EXAMINATION; THALASSEMIA MAJOR; VIRUS DETECTION;

EID: 77953388921     PISSN: 03044904     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Saleem M, Ahmad S, Khattak MF. An overview of thalassaemia in Pakistan proceedings 4th International Conference, Peshawar. Pakistan Association of Pathologists, 1996: 76.
2. Ahmad S. An approach for the prevention of thalassaemia in Pakistan. Ph D thesis, University of London.1998: 86-98.
3. Ahmad K. Hepatitis B in: Viral Hepatitis. An overview :Proceedings of seminar, AFIP Rawalpindi, Pakistan 1998;16-19.
4. Burki MFK, Hassan M, Chresion J, Prevalence of Anti-Hepatitis C Antibodies in Multiply transfused Beta Thalassaemia Major Patients, Annals Of Pakistan Institute of Medical Sciences, July-Sep 2005;1(3):150-153.
5. Nelson WE, Behrman RE, Kliegman RM and Avin AM. Nelson's Text Book of Pediatrics 17th Ed. Churchill Livingstone, London; 2001; 1401-1404.
6. Aach RD, Stevens CE, Hollinger FB. Hepatitis C virus infection in post-transfusion hepatitis - an analysis with first- and second-generation assays. N Engl J Med. 1991; 325: 1325.
7. Donahue JG, Munoz A, Ness PM et al. The declining risk of post-transfusion Hepatitis (Letter). N Engl J Med. 1992; 327: 369.
8. Nelson KE, Donahue JG, Stambolis V. Post-transfusion hepatitis C virus infection (Letter). N Engl J Med. 1992; 327: 1601.
9. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The retrovirus Epidemiology Donor Study: The risk of transfusion-transmitted viral infections. N Engl J Med. 1996; 334: 1685.
10. Blajchman MA, Bull SB, Feinman-SVTI. Post-transfusion hepatitis: Impact of non-A, non-B hepatitis surrogate tests. Lancet 1995; 345: 21.
11. Zurlo MF, De Stefano P, Borgna-Pignatti C et al. Survival and causes of death in thalassaemia major. Lancet 1989; 2: 27.
12. Rebulla P, Mozzi F, Contino G, Locatelli E, Sirchia G: Antibody to hepatitis C virus in 1305 Italian multiple transfused thalassaemia: Comparison of first and second generation tests. Tranfus Med. 1992; 2: 69.
13. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of Blood, 1997; 89: 739.
14. Kazmi K, Khan MAU, Phased introduction of Hepatitis B vaccination in Pakistan, Pak J Med Sci October-Dec 2007, 23(5): 913-916.
15. Sethi GR, et al. Immunogenicity of Recombinant Hepatitis B Vaccine in Thalassemic Children, 1999; 36: 498-501.
16. Choudhury N et al. Serological monitoring of thalassaemia major patients for transfusion associated viral infections Indian Journal of Medical Research June 1998.
17. Zali MR et al. Epidemiology of hepatitis B in the Islamic Republic of Iran, 1996; 2(2): 290-298.
18. Alavian SM et al. The Changing Epidemiology of Viral Hepatitis B in Iran; Research Center for Gastroenterology and Liver Disease, University of Medical Sciences, Baqiyatallah.
19. Mirmomen S et al. Epidemiology of Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infecions in Patients with Beta-Thalassemia in Iran: A Multicenter Study, Archives of Iranian October 2006; 9(4): 323.
20. Vahid T et al. Hepatitis B Prevalence and Risk Factors in Blood Donors in Ghazvin, IR. Iran, Hepatitis Monthly 2005; 5(4):117-122.
21. Singh H et al. High frequency of hepatitis B virus infection in patients with β-thalassemia receiving multiple transfusions Journal of Tropical Pediatrics 2001; 47(4): 239-242.
22. Mollah AH et al. Common Transfusion-transmitted Infectious Agents among Thalassaemic Children in Bangladesh J Health Popul Nutr 2003 Mar; 21(1): 67-71.
23. Presentation on health sector, Ministry of Health Govt. of Pakistan; May 2003.
24. Hepatitis B vaccine recombinant, GSK, Dec. 2006.
25. Shah SMA et al. Prevalence of Hepatitis B and Hepatitis C virus infection in multitransfused thalassaemia major patients in North West Frontier Province, Pak J Med Sci July-September 2005; 21(3): 281-284.